Oxirane

Oxirane

SCHEMBL607068

C1CO1.C=CCc1ccccc1OS(=O)(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 4/20 0.46
ADRB1 P08588 4/20 0.46
ADRB3 P13945 2/20 0.46
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 2/20 0.41
ADRA2C P18825 5/20 0.39
HTR1A P08908 4/20 0.39
ADRA2A P08913 4/20 0.39
ADRA2B P18089 4/20 0.39
NISCH Q9Y2I1 1/20 0.39
LMNA P02545 2/20 0.39
KCNH2 Q12809 2/20 0.39
SLC6A2 P23975 1/20 0.39
BDKRB2 P30411 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
HTR2B P41595 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174594 0.92 ALDH1A1 (0.44) ADRB2ADRB1ADRB3KDM4EALDH1A1
Ether SCHEMBL7133434 0.92 ADRB2 (0.41) ADRB2ADRB1ADRB3KDM4EALDH1A1
SCHEMBL10748390 0.91 ALDH1A1 (0.43) ADRB2ADRB1ADRB3KDM4EALDH1A1
SCHEMBL7242609 0.91 ALDH1A1 (0.43) ADRB2ADRB1ADRB3KDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL29695851 0.91 ALDH1A1 (0.43) ADRB2ADRB1ADRB3KDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL17304229 0.91 ALDH1A1 (0.43) ADRB2ADRB1ADRB3KDM4EALDH1A1
SCHEMBL4296256 0.88 ICAM1 (0.44) ADRB2ADRB1ADRB3KDM4EALDH1A1
Ether SCHEMBL1678479 0.84 ALDH1A1 (0.42) ADRB2ADRB1ADRB3KDM4EALDH1A1
SCHEMBL10533188 0.83 ADRB2 (0.44) ADRB2ADRB1ADRB3KDM4EALDH1A1
Ether SCHEMBL1074739 0.83 ALDH1A1 (0.41) ADRB2ADRB1ADRB3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 692 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118234837-A Manual detergent with decontamination function for pot, bowl, ladle and basin 埃科莱布美国股份有限公司 2024-06-21 CN claimed
WO-2023245313-A1 SOLID COMPOSITION FOR CLEANING, BLEACHING, AND SANITIZATION ECOLAB USA INC. (US) 2023-12-28 WO claimed
CN-117264698-A Solid compositions for cleaning, bleaching and disinfecting 埃科莱布美国股份有限公司 2023-12-22 CN claimed
WO-2023087194-A1 MANUAL DETERGENT FOR POT AND PAN WITH DESTAINING FUNCTION ECOLAB USA INC. (US) 2023-05-25 WO claimed
WO-2022104031-A2 METHODS AND COMPOSITIONS FOR REDUCING MICROBIAL CONTAMINANTS DURING POULTRY PROCESSING DIVERSEY, INC. (US) 2022-05-19 WO claimed
EP-1678289-B1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES COLGATE PALMOLIVE CO (US) 2007-04-11 EP claimed
EP-1701696-A1 ANHYDROUS SKIN CLEANSING AND SCRUBBING COMPOSITION Colgate-Palmolive Company (US) 2006-09-20 EP claimed
EP-1678289-A1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES Colgate-Palmolive Company (US) 2006-07-12 EP claimed
US-7045491-B2 Bar soap composition with reduced bar wear properties COLGATE-PALMOLIVE COMPANY (US) 2006-05-16 US claimed
US-6995130-B2 Blooming natural oil cleaning compositions CLARIANT FINANCE (BVI) LIMITED (VG) 2006-02-07 US claimed
US-20050107273-A1 Bar soap composition with reduced bar wear properties COLGATE-PALMOTIVE COMPANY 2005-05-19 US claimed
US-20050107278-A1 Blooming natural oil cleaning compositions CLARIANT INTERNATIONAL, LTD. 2005-05-19 US claimed
WO-2005044970-A1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES COLGATE-PALMOLIVE COMPANY (US) 2005-05-19 WO claimed
US-6864222-B1 Blooming natural oil cleaning compositions CLARIANT FINANCE (BVI) LIMITED (VG) 2005-03-08 US claimed
US-6730310-B2 VITAMIN E OR PRECURSOR ARE USED AS PROTECTING ANTIOXIDANT FOR SKIN EXPOSED TO OZONE; SKIN CARE AND CLEANSING COMPOUND COLGATE-PALMOLIVE COMPANY 2004-05-04 US claimed
EP-1047760-A1 GRANULAR COMPOSITIONS HAVING IMPROVED DISSOLUTION THE PROCTER & GAMBLE COMPANY (US) 2000-11-02 EP claimed
WO-1999036494-A1 GRANULAR COMPOSITIONS HAVING IMPROVED DISSOLUTION THE PROCTER & GAMBLE COMPANY (US) 1999-07-22 WO claimed
US-5759980-A ANIONIC, NONIONIC SURFACTANTS, SILICONE SURFACTANT, POLYMER; ELIMINATES SPOTTING BLUE CORAL, INC. (US) 1998-06-02 US claimed
EP-0003172-B2 The use of a deodorant detergent composition for suppressing human body malodour UNILEVER PLC (GB) 1997-03-19 EP claimed
EP-0003172-B1 The use of a deodorant detergent composition for suppressing human body malodour UNILEVER PLC (GB) 1987-10-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107273-A1 Bar soap composition with reduced bar wear properties DDHD2, SORD, CRABP2 ADRB2 3169/4885ADRB1 3888/4885ADRB3 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.